Poseida Therapeutics Inc. (PSTX) NASDAQ
$3.19 (0.16) (-4.63%)
Market Cap: $309.29M
As of 05/17/24 04:00 PM EDT. Market closed.
Poseida Therapeutics Inc. (PSTX)
NASDAQ
$3.19
(0.16) (-4.63%)
Market Cap: $309.29M
As of 05/17/24 04:00 PM EDT. Market closed.
Add to Portfolio
poseida therapeutics, inc. is currently developing car-t and gene therapy products for cancer and orphan diseases. spinout of transposagen biopharmaceuticals early this year, poseida is also collaborating with j&j’s janssen to develop allogeneic car-t therapies against cancer. poseida boasts best-in-class genome engineering capabilities for effectively silencing target genes or inserting ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Eric Ostertag
Full Time Employees
307
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Eric Ostertag
Full Time Employees
307
URL
Address
9390 Towne Centre Drive, Suite 200, California, San Diego, 92121.
PRICE CHART FOR POSEIDA THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.25
Previous Close
$3.35
Days Range
$3.13 - $3.35
52 week range
$1.54 - $4.27
Volume
520,405
Avg. Volume (30 days)
650,897
Market Cap
$309.29M
Dividend Yield
-
P/E
(2.84)
Shares Outstanding
96,957,650
Open
$3.25
Previous Close
$3.35
Days Range
$3.13 - $3.35
52 week range
$1.54 - $4.27
Volume
520,405
Avg. Volume (30 days)
650,897
Market Cap
$309.29M
Dividend Yield
-
P/E
(2.84)
Shares Outstanding
96,957,650
FINANCIAL STATEMENTS FOR POSEIDA THERAPEUTICS INC
LOADING...
INSIDER TRANSACTIONS FOR POSEIDA THERAPEUTICS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Mylet Johanna | Chief Financial Officer | Mar 01, 2024 | Option Exercise | $4.13 | 18,091 | 74,716 | 246,283 | Mar 04, 2024, 05:29 PM |
Gergen Mark J | Executive Chairman | Feb 01, 2024 | Option Exercise | $3.41 | 47,162 | 160,822 | 685,448 | Feb 02, 2024, 08:51 PM |
Warner Brent | President, Gene Therapy | Mar 01, 2023 | Option Exercise | $5.35 | 26,617 | 142,401 | 374,036 | Mar 02, 2023, 06:30 PM |
Mylet Johanna | Chief Financial Officer | Mar 01, 2023 | Option Exercise | $5.35 | 4,323 | 23,128 | 177,631 | Mar 02, 2023, 06:28 PM |
LEONHARDT HARRY J | GC & Chief Compliance Officer | Mar 01, 2023 | Option Exercise | $5.35 | 4,323 | 23,128 | 144,203 | Mar 02, 2023, 06:26 PM |
Ostertag Eric | Director | Feb 01, 2023 | Option Exercise | $7.00 | 11,776 | 82,432 | 827,320 | Feb 03, 2023, 04:19 PM |
Gergen Mark J | President and CEO | Feb 01, 2023 | Option Exercise | $7.00 | 31,819 | 222,733 | 330,314 | Feb 03, 2023, 04:16 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Aug 08, 2022 | Buy | $3.50 | 2,150,000 | 7,525,000 | 11,835,673 | Aug 10, 2022, 08:49 PM |
Ostertag Eric | Executive Chairman | Aug 08, 2022 | Buy | $3.50 | 142,857 | 500,000 | 838,824 | Aug 10, 2022, 06:13 PM |
Ostertag Eric | Executive Chairman | Aug 03, 2022 | Sale | $3.69 | 160,696 | 592,808 | 0 | Aug 05, 2022, 04:09 PM |
Ingalls Kerry D. | Chief Operating Officer | Mar 16, 2022 | Buy | $3.98 | 3,000 | 11,940 | 55,000 | Mar 18, 2022, 08:01 PM |
Mylet Johanna | Chief Financial Officer | Dec 21, 2021 | Option Exercise | $1.59 | 5,716 | 9,061 | 34,231 | Dec 22, 2021, 04:53 PM |
Spear Matthew A. | Chief Medical Officer | Dec 06, 2021 | Option Exercise | $1.32 | 10,000 | 13,220 | 61,485 | Dec 08, 2021, 08:38 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Dec 06, 2021 | Buy | $6.90 | 1,828 | 12,613 | 9,685,673 | Dec 07, 2021, 06:03 AM |
Malin Life Sciences Holdings Ltd | 10% Owner | Nov 30, 2021 | Buy | $6.85 | 28,592 | 195,838 | 9,661,184 | Dec 02, 2021, 06:33 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Dec 02, 2021 | Buy | $6.88 | 4,296 | 29,550 | 9,683,845 | Dec 02, 2021, 06:33 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Dec 01, 2021 | Buy | $6.85 | 18,365 | 125,806 | 9,679,549 | Dec 02, 2021, 06:33 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Nov 29, 2021 | Buy | $6.89 | 11,057 | 76,209 | 9,632,592 | Nov 29, 2021, 07:55 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Nov 26, 2021 | Buy | $6.81 | 27,251 | 185,492 | 9,621,535 | Nov 29, 2021, 07:55 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Nov 24, 2021 | Buy | $6.89 | 1,054 | 7,260 | 9,594,284 | Nov 29, 2021, 07:55 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Nov 23, 2021 | Buy | $6.77 | 14,625 | 98,989 | 9,593,230 | Nov 23, 2021, 06:41 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Nov 19, 2021 | Buy | $7.44 | 11,104 | 82,650 | 9,578,605 | Nov 23, 2021, 06:41 PM |
Ostertag Eric | Chief Executive Officer | Nov 19, 2021 | Option Exercise | $9.15 | 1,000 | 9,150 | 697,422 | Nov 22, 2021, 07:50 PM |
Ingalls Kerry D. | Chief Operating Officer | Nov 17, 2021 | Buy | $7.00 | 2,000 | 14,000 | 2,000 | Nov 18, 2021, 09:12 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Nov 18, 2021 | Buy | $7.18 | 71,312 | 511,685 | 9,567,501 | Nov 18, 2021, 08:24 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Nov 17, 2021 | Buy | $7.21 | 280,384 | 2,021,821 | 9,496,189 | Nov 18, 2021, 08:24 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Nov 16, 2021 | Buy | $7.17 | 27,680 | 198,383 | 9,215,805 | Nov 18, 2021, 08:24 PM |
Ostertag Eric | Chief Executive Officer | Nov 08, 2021 | Sale | $7.09 | 18,924 | 134,171 | 3,659,503 | Nov 10, 2021, 06:06 PM |
Ostertag Eric | Chief Executive Officer | Oct 11, 2021 | Option Exercise | $9.15 | 18,525 | 169,504 | 696,422 | Oct 13, 2021, 06:59 PM |
Ostertag Eric | Chief Executive Officer | Oct 01, 2021 | Sale | $7.02 | 20,029 | 140,604 | 3,669,376 | Oct 05, 2021, 06:16 PM |
Ostertag Eric | Chief Executive Officer | Sep 20, 2021 | Sale | $8.00 | 20,000 | 160,020 | 160,696 | Sep 22, 2021, 05:51 PM |
Ostertag Eric | Chief Executive Officer | Sep 13, 2021 | Option Exercise | $8.12 | 21,281 | 172,729 | 675,415 | Sep 15, 2021, 06:58 PM |
Ostertag Eric | Chief Executive Officer | Sep 14, 2021 | Sale | $8.14 | 20,000 | 162,712 | 180,696 | Sep 15, 2021, 06:58 PM |
Spear Matthew A. | Chief Medical Officer | Sep 09, 2021 | Option Exercise | $1.32 | 10,000 | 13,220 | 51,485 | Sep 10, 2021, 04:19 PM |
Ostertag Eric | Chief Executive Officer | Sep 01, 2021 | Sale | $8.46 | 51,149 | 432,721 | 3,711,789 | Sep 03, 2021, 04:54 PM |
Ostertag Eric | Chief Executive Officer | Sep 02, 2021 | Sale | $8.34 | 61,262 | 510,925 | 3,679,826 | Sep 03, 2021, 04:54 PM |
Spear Matthew A. | Chief Medical Officer | Aug 20, 2021 | Option Exercise | $1.32 | 4,000 | 5,288 | 45,485 | Aug 24, 2021, 05:12 PM |
Spear Matthew A. | Chief Medical Officer | Aug 20, 2021 | Sale | $8.79 | 4,000 | 35,142 | 41,485 | Aug 24, 2021, 05:12 PM |
Ostertag Eric | Chief Executive Officer | Aug 06, 2021 | Option Exercise | $9.15 | 111,149 | 1,017,013 | 654,134 | Aug 10, 2021, 06:56 PM |
Ostertag Eric | Chief Executive Officer | Aug 03, 2021 | Sale | $7.99 | 19,936 | 159,289 | 3,738,475 | Aug 04, 2021, 04:57 PM |
Ostertag Eric | Chief Executive Officer | Aug 02, 2021 | Sale | $8.13 | 13,737 | 111,682 | 3,748,876 | Aug 04, 2021, 04:57 PM |
Spear Matthew A. | Chief Medical Officer | Jul 28, 2021 | Option Exercise | $1.32 | 20,000 | 26,440 | 41,485 | Jul 30, 2021, 04:29 PM |
Ostertag Eric | Chief Executive Officer | Jul 02, 2021 | Sale | $8.91 | 27,542 | 245,274 | 3,770,309 | Jul 06, 2021, 05:35 PM |
Ostertag Eric | Chief Executive Officer | Jul 01, 2021 | Sale | $9.77 | 20,563 | 200,901 | 3,770,413 | Jul 06, 2021, 05:35 PM |
Spear Matthew A. | Chief Medical Officer | Jun 17, 2021 | Option Exercise | $1.32 | 5,000 | 6,610 | 21,485 | Jun 21, 2021, 08:02 PM |
Spear Matthew A. | Chief Medical Officer | Jun 11, 2021 | Option Exercise | $1.32 | 4,000 | 5,288 | 20,485 | Jun 14, 2021, 06:18 PM |
Spear Matthew A. | Chief Medical Officer | Jun 11, 2021 | Sale | $9.44 | 4,000 | 37,747 | 16,485 | Jun 14, 2021, 06:18 PM |
Ostertag Eric | Chief Executive Officer | Jun 01, 2021 | Sale | $8.61 | 41,194 | 354,680 | 3,802,388 | Jun 03, 2021, 07:21 PM |
Ostertag Eric | Chief Executive Officer | Jun 02, 2021 | Sale | $8.34 | 40,722 | 339,621 | 3,781,142 | Jun 03, 2021, 07:21 PM |
Ostertag Eric | Chief Executive Officer | May 04, 2021 | Sale | $8.44 | 35,986 | 303,722 | 3,823,881 | May 05, 2021, 07:29 PM |
Ostertag Eric | Chief Executive Officer | May 03, 2021 | Sale | $9.01 | 18,326 | 165,117 | 3,842,656 | May 05, 2021, 07:29 PM |
Spear Matthew A. | Chief Medical Officer | Apr 23, 2021 | Option Exercise | $1.32 | 5,000 | 6,610 | 16,485 | Apr 23, 2021, 08:49 PM |
Spear Matthew A. | Chief Medical Officer | Apr 21, 2021 | Option Exercise | $1.32 | 4,000 | 5,288 | 15,485 | Apr 23, 2021, 08:49 PM |
Spear Matthew A. | Chief Medical Officer | Apr 21, 2021 | Sale | $8.44 | 4,000 | 33,752 | 11,485 | Apr 23, 2021, 08:49 PM |
Ostertag Eric | Chief Executive Officer | Apr 01, 2021 | Sale | $9.55 | 57,181 | 546,330 | 3,882,383 | Apr 05, 2021, 07:50 PM |
Ostertag Eric | Chief Executive Officer | Apr 05, 2021 | Sale | $9.66 | 57,819 | 558,668 | 3,853,834 | Apr 05, 2021, 07:50 PM |
Ostertag Eric | Chief Executive Officer | Mar 02, 2021 | Sale | $11.54 | 57,060 | 658,415 | 3,912,217 | Mar 03, 2021, 07:38 PM |
Ostertag Eric | Chief Executive Officer | Mar 01, 2021 | Sale | $11.67 | 57,940 | 676,046 | 3,942,515 | Mar 03, 2021, 07:38 PM |
Ostertag Eric | Chief Executive Officer | Feb 23, 2021 | Option Exercise | $1.17 | 111,395 | 130,666 | 542,985 | Feb 25, 2021, 07:01 PM |
Ostertag Eric | Chief Executive Officer | Feb 16, 2021 | Sale | $10.00 | 133,149 | 1,332,036 | 200,696 | Feb 17, 2021, 05:28 PM |
Ostertag Eric | Chief Executive Officer | Feb 10, 2021 | Option Exercise | $1.29 | 67,534 | 87,119 | 431,590 | Feb 12, 2021, 05:03 PM |
Ostertag Eric | Chief Executive Officer | Feb 10, 2021 | Sale | $10.00 | 12,389 | 123,890 | 333,845 | Feb 12, 2021, 05:03 PM |
Ostertag Eric | Chief Executive Officer | Jan 21, 2021 | Sale | $10.00 | 4,462 | 44,620 | 346,234 | Jan 25, 2021, 07:42 PM |
Mylet Johanna | Senior Vice President, Finance | Jan 15, 2021 | Option Exercise | $0.30 | 4,728 | 1,418 | 26,813 | Jan 19, 2021, 05:00 PM |
Spear Matthew A. | Chief Medical Officer | Jan 15, 2021 | Option Exercise | $1.32 | 7,564 | 10,000 | 11,485 | Jan 19, 2021, 05:00 PM |
Spear Matthew A. | Chief Medical Officer | Jan 08, 2021 | Option Exercise | $1.32 | 3,921 | 5,184 | 3,921 | Jan 11, 2021, 05:00 PM |
Murphy Sean | Director | Jul 14, 2020 | Buy | $16.00 | 10,000 | 160,000 | 10,000 | Jul 15, 2020, 05:00 PM |
Hirsch David | Director | Jul 14, 2020 | Buy | $16.00 | 250,000 | 4,000,000 | 2,714,245 | Jul 15, 2020, 05:00 PM |
Lloyd Marcea Bland | Director | Jul 14, 2020 | Buy | $16.00 | 10,000 | 160,000 | 10,000 | Jul 15, 2020, 05:00 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Mylet Johanna | Chief Financial Officer | 03/01/2024 | 74,716 |
Gergen Mark J | Executive Chairman | 02/01/2024 | 160,822 |
Warner Brent | President, Gene Therapy | 03/01/2023 | 142,401 |
Mylet Johanna | Chief Financial Officer | 03/01/2023 | 23,128 |
LEONHARDT HARRY J | GC & Chief Compliance Officer | 03/01/2023 | 23,128 |
Ostertag Eric | Director | 02/01/2023 | 82,432 |
Gergen Mark J | President and CEO | 02/01/2023 | 222,733 |
Malin Life Sciences Holdings Ltd | 10% Owner | 08/08/2022 | 7,525,000 |
Ostertag Eric | Executive Chairman | 08/08/2022 | 500,000 |
Ostertag Eric | Executive Chairman | 08/03/2022 | 592,808 |
Ingalls Kerry D. | Chief Operating Officer | 03/16/2022 | 11,940 |
Mylet Johanna | Chief Financial Officer | 12/21/2021 | 9,061 |
Spear Matthew A. | Chief Medical Officer | 12/06/2021 | 13,220 |
Malin Life Sciences Holdings Ltd | 10% Owner | 12/06/2021 | 12,613 |
Malin Life Sciences Holdings Ltd | 10% Owner | 11/30/2021 | 195,838 |
Malin Life Sciences Holdings Ltd | 10% Owner | 12/02/2021 | 29,550 |
Malin Life Sciences Holdings Ltd | 10% Owner | 12/01/2021 | 125,806 |
Malin Life Sciences Holdings Ltd | 10% Owner | 11/29/2021 | 76,209 |
Malin Life Sciences Holdings Ltd | 10% Owner | 11/26/2021 | 185,492 |
Malin Life Sciences Holdings Ltd | 10% Owner | 11/24/2021 | 7,260 |
Malin Life Sciences Holdings Ltd | 10% Owner | 11/23/2021 | 98,989 |
Malin Life Sciences Holdings Ltd | 10% Owner | 11/19/2021 | 82,650 |
Ostertag Eric | Chief Executive Officer | 11/19/2021 | 9,150 |
Ingalls Kerry D. | Chief Operating Officer | 11/17/2021 | 14,000 |
Malin Life Sciences Holdings Ltd | 10% Owner | 11/18/2021 | 511,685 |
Malin Life Sciences Holdings Ltd | 10% Owner | 11/17/2021 | 2,021,821 |
Malin Life Sciences Holdings Ltd | 10% Owner | 11/16/2021 | 198,383 |
Ostertag Eric | Chief Executive Officer | 11/08/2021 | 134,171 |
Ostertag Eric | Chief Executive Officer | 10/11/2021 | 169,504 |
Ostertag Eric | Chief Executive Officer | 10/01/2021 | 140,604 |
Ostertag Eric | Chief Executive Officer | 09/20/2021 | 160,020 |
Ostertag Eric | Chief Executive Officer | 09/13/2021 | 172,729 |
Ostertag Eric | Chief Executive Officer | 09/14/2021 | 162,712 |
Spear Matthew A. | Chief Medical Officer | 09/09/2021 | 13,220 |
Ostertag Eric | Chief Executive Officer | 09/01/2021 | 432,721 |
Ostertag Eric | Chief Executive Officer | 09/02/2021 | 510,925 |
Spear Matthew A. | Chief Medical Officer | 08/20/2021 | 5,288 |
Spear Matthew A. | Chief Medical Officer | 08/20/2021 | 35,142 |
Ostertag Eric | Chief Executive Officer | 08/06/2021 | 1,017,013 |
Ostertag Eric | Chief Executive Officer | 08/03/2021 | 159,289 |
Ostertag Eric | Chief Executive Officer | 08/02/2021 | 111,682 |
Spear Matthew A. | Chief Medical Officer | 07/28/2021 | 26,440 |
Ostertag Eric | Chief Executive Officer | 07/02/2021 | 245,274 |
Ostertag Eric | Chief Executive Officer | 07/01/2021 | 200,901 |
Spear Matthew A. | Chief Medical Officer | 06/17/2021 | 6,610 |
Spear Matthew A. | Chief Medical Officer | 06/11/2021 | 5,288 |
Spear Matthew A. | Chief Medical Officer | 06/11/2021 | 37,747 |
Ostertag Eric | Chief Executive Officer | 06/01/2021 | 354,680 |
Ostertag Eric | Chief Executive Officer | 06/02/2021 | 339,621 |
Ostertag Eric | Chief Executive Officer | 05/04/2021 | 303,722 |
Ostertag Eric | Chief Executive Officer | 05/03/2021 | 165,117 |
Spear Matthew A. | Chief Medical Officer | 04/23/2021 | 6,610 |
Spear Matthew A. | Chief Medical Officer | 04/21/2021 | 5,288 |
Spear Matthew A. | Chief Medical Officer | 04/21/2021 | 33,752 |
Ostertag Eric | Chief Executive Officer | 04/01/2021 | 546,330 |
Ostertag Eric | Chief Executive Officer | 04/05/2021 | 558,668 |
Ostertag Eric | Chief Executive Officer | 03/02/2021 | 658,415 |
Ostertag Eric | Chief Executive Officer | 03/01/2021 | 676,046 |
Ostertag Eric | Chief Executive Officer | 02/23/2021 | 130,666 |
Ostertag Eric | Chief Executive Officer | 02/16/2021 | 1,332,036 |
Ostertag Eric | Chief Executive Officer | 02/10/2021 | 87,119 |
Ostertag Eric | Chief Executive Officer | 02/10/2021 | 123,890 |
Ostertag Eric | Chief Executive Officer | 01/21/2021 | 44,620 |
Mylet Johanna | Senior Vice President, Finance | 01/15/2021 | 1,418 |
Spear Matthew A. | Chief Medical Officer | 01/15/2021 | 10,000 |
Spear Matthew A. | Chief Medical Officer | 01/08/2021 | 5,184 |
Murphy Sean | Director | 07/14/2020 | 160,000 |
Hirsch David | Director | 07/14/2020 | 4,000,000 |
Lloyd Marcea Bland | Director | 07/14/2020 | 160,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN POSEIDA THERAPEUTICS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
PENTWATER CAPITAL MANAGEMENT LP | 5,975,000 | 0.2% | No change | Event Driven |
BLACKROCK INC. | 4,950,070 | 0.00037% | -1.61% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,563,360 | 0.00046% | 2.65% | Other |
RENAISSANCE TECHNOLOGIES LLC | 557,400 | 0.00279% | 5.15% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 56,837 | 0.00032% | New | Event Driven |
AQR CAPITAL MANAGEMENT LLC | 10,859 | 0.00006% | -54.07% | Other |
CHANGE IN SHARES OUTSTANDING FOR POSEIDA THERAPEUTICS INC
STOCK BUYBACKS FOR POSEIDA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
4.22%
1Q
06/30/2023
10.35%
2Q
03/31/2023
11.02%
3Q
12/31/2022
11.23%
4Q
09/30/2022
24.89%
5Q
06/30/2022
52.72%
6Q
03/31/2022
53.10%
7Q
12/31/2021
53.21%
8Q
09/30/2021
53.74%
9Q
06/30/2021
54.10%
10Q
03/31/2021
54.52%
11Q
09/30/2020
74.22%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR POSEIDA THERAPEUTICS INC
LOADING...